Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Single-Channel Pipette

By Drug Discovery Trends Editor | November 30, 2009

FinnpipetteThermo Fisher Scientific Inc. announced the Finnpipette F2 with an upgraded soft-touch tip ejector for increased ergonomics. With a patented gearing mechanism, the tip ejection force is decreased by up to 50 percent, effectively reducing the risk of repetitive strain injury (RSI). The combination of soft-touch tip ejector, softly contoured handle and wide, supportive finger rest provides a comfortable and easy-to-use pipette. Furthermore, the advanced volume-gearing mechanism allows superior volume precision within two decimal places, and the double-action pipetting button prevents volume drift during pipetting. As general laboratory pipettes, the Finnpipette® F2, with increased ergonomics, is suitable for all routine laboratory applications.

The Finnpipette F2 includes a range of variable and fixed volume single-channel pipettes covering 0.2 µl to 10 ml for assured versatility. Multi-channel models are also available, with volumes ranging from 1 to 300 µl, for every application. Each F2 pipette is color-coded to facilitate quick and easy pairing with the corresponding Thermo Scientific Finntip. Furthermore, they are fully autoclavable to prevent contamination between samples. With a clear, easy-to-read black and white display, volumes can be set quickly, with the knowledge that an accurate amount will be dispensed each time.

Thermo Fisher Scientific Inc. 


Filed Under: Drug Discovery

 

Related Articles Read More >

TransCelerate CEO Janice Chang wants trials to become part of routine care
STEERLife’s FragMelt platform manufactures drugs with heat sensitive active ingredient 
S&P report highlights Big Pharma’s concentration risk amid pre-JPM deal flurry
Eli Lilly in the Drug Discovery & Development Pharma 50
Lilly Phase 3b trial shows roughly 40-fold higher combined arthritis and weight-loss response
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE